Liquiritigenin ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function, reducing endoplasmic reticulum stress and modulating gut microbiota

This publication has 59 references indexed in Scilit:

• Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics
  Digestive Diseases and Sciences, 2023
• Roles of genistein in learning and memory during aging and neurological disorders
  Biogerontology, 2023
• The influence of cytokines on the complex pathology of ulcerative colitis
  Autoimmunity Reviews, 2022
• Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy
  Biomedicine & Pharmacotherapy, 2021
• Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease
  Archives of Biochemistry and Biophysics, 2021
• NF-κB and Nrf2 pathways contribute to the protective effect of Licochalcone A on dextran sulphate sodium-induced ulcerative colitis in mice
  Biomedicine & Pharmacotherapy, 2018
• Liquiritigenin prevents palmitate-induced beta-cell apoptosis via estrogen receptor-mediated AKT activation
  Biomedicine & Pharmacotherapy, 2018
• Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease
  Archives of Biochemistry and Biophysics, 2018
• Drug Resistance Reversal Potential of Isoliquiritigenin and Liquiritigenin Isolated fromGlycyrrhiza glabraAgainst Methicillin-ResistantStaphylococcus aureus(MRSA)
  Phytotherapy Research, 2016
• Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
  Phytotherapy Research, 2008